v3.26.1
BUSINESS SEGMENT INFORMATION
 9 Months Ended
Jun. 30, 2026
BUSINESS SEGMENT INFORMATION [Abstract]  
BUSINESS SEGMENT INFORMATION
11.     BUSINESS SEGMENT INFORMATION
 
As referenced above in Note 1 - "Basis of Presentation and Significant Accounting Policies", the Company operates in three reportable segments: Logistics, Life Sciences and Manufacturing.
 
The Company’s Chief Executive Officer, who is the Chief Operating Decision Maker (“CODM”), regularly reviews financial information at the reporting segment level in order to make decisions about resources to be allocated to the segments and to assess their performance.
 
The following tables present selected financial information about the Company’s reportable segments and Corporate for the purpose of reconciling to the consolidated totals for the three and nine months ended June 30, 2026:
 
                     
                     
For the three months ended June 30, 2026
  Consolidated     Logistics     Life 
Sciences
    Manufacturing     Corporate  
Revenues
 $67,512   $61,081   $3,858   $2,573   $ - 
Forwarding expenses and cost of revenues
  46,027    43,973    842    1,212    - 
Gross profit
  21,485    17,108    3,016    1,361    - 
Selling, general and administrative
  16,801    11,603    2,478    897    1,823 
Amortization of intangible assets
  1,043    -    -    -    1,043 
Income (loss) from operations
  3,641    5,505    538    464    (2,866) 
Interest expense
  552    271    212    69    - 
Identifiable assets
  192,000    95,462    14,584    7,693    74,261 
Capital expenditures, net of disposals
  34    15    14    5    - 
 
                     
For the nine months ended June 30, 2026
  Consolidated     Logistics     Life Sciences
 
 Manufacturing 
 Corporate 
Revenues
 $180,995   $163,394   $10,663   $6,938   $ - 
Forwarding expenses and cost of revenues
  122,825    117,507    2,044    3,274    - 
Gross profit
  58,170    45,887    8,619    3,664    - 
Selling, general and administrative
  49,305    33,494    7,270    2,670    5,871 
Amortization of intangible assets
  2,701    -    -    -    2,701 
Income (loss) from operations
  6,164    12,393    1,349    994    (8,572) 
Interest expense
  1,267    643    404    214    6 
Identifiable assets
  192,000    95,462    14,584    7,693    74,261 
Capital expenditures, net of disposals
  198    24    165    9    - 
 
The Manufacturing segment includes results from Rubicon starting on the acquisition date of October 14, 2025. Rubicon’s corporate expenses are included in Janel’s Corporate expenses segment.
 
The following tables present selected financial information about the Company’s reportable segments and Corporate for the purpose of reconciling to the consolidated totals for the three and nine months ended June 30, 2025:
 
                     
For the three months ended June 30, 2025
  Consolidated     Logistics     Life
 Sciences
    Manufacturing     Corporate  
Revenues
 $49,145   $43,231   $3,490   $2,424   $ - 
Forwarding expenses and cost of revenues
  33,035    31,259    624    1,152    - 
Gross profit
  16,110    11,972    2,866    1,272    - 
Selling, general and administrative
  13,525    9,434    2,062    764    1,265 
Amortization of intangible assets
  654    -    -    -    654 
Income (loss) from operations
  1,931    2,538    804    508   (1,919)
Interest expense
  442    289    73    80    - 
Identifiable assets
  126,032    52,255    13,349    4,453    55,975 
Capital expenditures, net of disposals
  69    5    45    19    - 
                     
For the nine months ended June 30, 2025
  Consolidated     Logistics     Life
Sciences 		    Manufacturing     Corporate  
Revenues
 $151,230   $133,361   $10,639   $7,230   $ - 
Forwarding expenses and cost of revenues
  103,407    98,155    1,870    3,382    - 
Gross profit
  47,823    35,206    8,769    3,848    - 
Selling, general and administrative
  40,576    28,327    5,979    2,507    3,763 
Amortization of intangible assets
  1,937    -    -    -    1,937 
Income (loss) from operations
  5,310    6,879    2,790    1,341    (5,700) 
Interest expense
  1,668    1,168    280    220    - 
Identifiable assets
  126,032    52,255    13,349    4,453    55,975 
Capital expenditures, net of disposals
  396    31    346    19    -